135 related articles for article (PubMed ID: 11849694)
1. Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay.
Ross RS; Viazov S; Sarr S; Hoffmann S; Kramer A; Roggendorf M
J Virol Methods; 2002 Mar; 101(1-2):159-68. PubMed ID: 11849694
[TBL] [Abstract][Full Text] [Related]
2. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test.
Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
J Clin Microbiol; 2000 Aug; 38(8):2933-9. PubMed ID: 10921954
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy.
Veillon P; Payan C; Picchio G; Maniez-Montreuil M; Guntz P; Lunel F
J Clin Microbiol; 2003 Jul; 41(7):3212-20. PubMed ID: 12843066
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice.
Shiffman ML; Ferreira-Gonzalez A; Reddy KR; Sterling RK; Luketic VA; Stravitz RT; Sanyal AJ; Garrett CT; De Medina M; Schiff ER
Am J Gastroenterol; 2003 May; 98(5):1159-66. PubMed ID: 12809843
[TBL] [Abstract][Full Text] [Related]
6. Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C.
Martinot-Peignoux M; Khiri H; Leclere L; Maylin S; Marcellin P; Halfon P
J Clin Virol; 2009 Nov; 46(3):216-21. PubMed ID: 19748822
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum.
Germer JJ; Heimgartner PJ; Ilstrup DM; Harmsen WS; Jenkins GD; Patel R
J Clin Microbiol; 2002 Feb; 40(2):495-500. PubMed ID: 11825962
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia.
Furusyo N; Hayashi J; Kashiwagi K; Nakashima H; Nabeshima S; Sawayama Y; Kinukawa N; Kashiwagi S
Dig Dis Sci; 2002 Mar; 47(3):535-42. PubMed ID: 11911338
[TBL] [Abstract][Full Text] [Related]
9. Performance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay.
Beld M; Sentjens R; Rebers S; Weegink C; Weel J; Sol C; Boom R
J Clin Microbiol; 2002 Mar; 40(3):788-93. PubMed ID: 11880394
[TBL] [Abstract][Full Text] [Related]
10. TaqMan amplification system with an internal positive control for HCV RNA quantitation.
Castelain S; Descamps V; Thibault V; François C; Bonte D; Morel V; Izopet J; Capron D; Zawadzki P; Duverlie G
J Clin Virol; 2004 Nov; 31(3):227-34. PubMed ID: 15465417
[TBL] [Abstract][Full Text] [Related]
11. Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay.
Lu RH; Hwang SJ; Chan CY; Chang FY; Lee SD
J Clin Lab Anal; 1998; 12(2):121-5. PubMed ID: 9524297
[TBL] [Abstract][Full Text] [Related]
12. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
Gelderblom HC; Menting S; Beld MG
Antivir Ther; 2006; 11(1):95-103. PubMed ID: 16518965
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA.
Yu ML; Chuang WL; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
J Clin Pathol; 1999 Nov; 52(11):807-11. PubMed ID: 10690168
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay.
Pittaluga F; Allice T; Abate ML; Ciancio A; Cerutti F; Varetto S; Colucci G; Smedile A; Ghisetti V
J Med Virol; 2008 Feb; 80(2):254-60. PubMed ID: 18098148
[TBL] [Abstract][Full Text] [Related]
15. Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays.
Pawlotsky JM; Martinot-Peignoux M; Poveda JD; Bastie A; Le Breton V; Darthuy F; Rémiré J; Erlinger S; Dhumeaux D; Marcellin P
J Virol Methods; 1999 May; 79(2):227-35. PubMed ID: 10381092
[TBL] [Abstract][Full Text] [Related]
16. Assessment of early virological response to antiviral therapy by comparing four assays for HCV RNA quantitation using the international unit standard: implications for clinical management of patients with chronic hepatitis C virus infection.
Halfon P; Pénaranda G; Bourlière M; Khiri H; Masseyeff MF; Ouzan D
J Med Virol; 2006 Feb; 78(2):208-15. PubMed ID: 16372298
[TBL] [Abstract][Full Text] [Related]
17. Comparison of real-time quantitative polymerase chain reaction with three other assays for quantitation of hepatitis C virus.
Enomoto M; Nishiguchi S; Shiomi S; Tanaka M; Fukuda K; Ueda T; Tamori A; Habu D; Takeda T; Yano Y; Otani S
J Gastroenterol Hepatol; 2001 Aug; 16(8):904-9. PubMed ID: 11555105
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.
Lunel F; Cresta P; Vitour D; Payan C; Dumont B; Frangeul L; Reboul D; Brault C; Piette JC; Huraux JM
Hepatology; 1999 Feb; 29(2):528-35. PubMed ID: 9918931
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the clinical usefulness of COBAS AMPLICOR HCV MONITOR assay (ver2.0): Comparison with AMPLICOR HCV MONITOR assay (ver1.0) and HCV core protein level.
Kawai S; Yokosuka O; Imazeki F; Saisho H; Mizuno C
J Med Virol; 2002 Nov; 68(3):343-51. PubMed ID: 12226820
[TBL] [Abstract][Full Text] [Related]
20. A comparative evaluation between real time Roche COBas TAQMAN 48 HCV and bDNA Bayer Versant HCV 3.0.
Giraldi C; Noto A; Tenuta R; Greco F; Perugini D; Spadafora M; Bianco AM; Savino O; Natale A
New Microbiol; 2006 Oct; 29(4):243-50. PubMed ID: 17201090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
